He said that "to date, a prototype of the vaccine has been created, it is called in a different way the candidate vaccine."

Gusakov said that "now all that remains is to test it on animals, to undergo preclinical and clinical trials."

“We hope that next year we will pass it on for widespread vaccination ... The issue of the production of our vaccine is being worked out by the Ministry of Health, but in principle we have coped with this task,” the head of the NAS is quoted by TASS.

Earlier in Belarus, the number of recorded cases of coronavirus infection COVID-19 reached 445,048.